<SEC-DOCUMENT>0000920465-20-000119-index.html : 20200729
<SEC-HEADER>0000920465-20-000119.hdr.sgml : 20200729
<ACCEPTANCE-DATETIME>20200728173629
ACCESSION NUMBER:		0000920465-20-000119
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200728
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200729
DATE AS OF CHANGE:		20200728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		201054900

	BUSINESS ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ljpc-ttphclosing8xk_72820x.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: ljpc-ttphclosing8xk_72820x.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ljpc_tetraphase-cvragreeme.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
Document 2 - file: ljpc_tetraphase-cvragreeme.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ljpctetraphasecvragre_image1.gif
<TEXT>
Document 3 - file: ljpctetraphasecvragre_image1.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ljpctetraphasecvragre_image2.gif
<TEXT>
Document 4 - file: ljpctetraphasecvragre_image2.gif

</DOCUMENT>
</SEC-DOCUMENT>